Literature DB >> 31980870

Discriminating Between Non-Specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis at Early Stages: When CPET is Enough?

Afroditi K Boutou1.   

Abstract

Entities:  

Year:  2020        PMID： 31980870     DOI： 10.1007/s00408-019-00316-2

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  5 in total

Review 1.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

2.  Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.

Authors:  Lauren Rose; Kurt W Prins; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Jeffrey R Misialek; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2018-09-14       Impact factor: 10.247

3.  Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung disease.

Authors:  Peter M George; Jane A Mitchell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-21       Impact factor: 5.464

4.  Non-invasive markers of pulmonary hypertension in interstitial lung disease: is cardiopulmonary exercise testing the Holy Grail?

Authors:  Afroditi K Boutou; Georgia G Pitsiou; Paraskevi Argyropoulou
Journal:  Respirology       Date:  2014-05-15       Impact factor: 6.424

5.  Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease.

Authors:  Lars Hagmeyer; Simon Herkenrath; Norbert Anduleit; Marcel Treml; Winfried Randerath
Journal:  Lung       Date:  2019-11-01       Impact factor: 2.584
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.